光大證券(06178.HK):中國證監會對公司試點開展基金投資顧問業務無異議
格隆匯7月5日丨光大證券(06178.HK)發佈公吿,公司近日收到中國證券監督管理委員會《關於光大證券股份有限公司試點開展基金投資顧問業務有關事項的覆函》。根據該覆函,中國證監會對公司試點開展基金投資顧問業務無異議。
公司將按照《試點通知》以及公司報送的試點業務方案儘快完成基金投資顧問業務相關籌備工作,並待通過驗收後,正式開展基金投資顧問試點業務。基金投資顧問業務試點期限為一年,展業一年以後,公司將按照要求申請續展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.